Latest Breaking News On - Sun pharmaceutical - Page 19 : comparemela.com

AbbVie suing Sandoz, four others to block generic Rinvoq: report (NYSE:ABBV)

AbbVie suing Sandoz, four others to block generic Rinvoq: report (NYSE:ABBV)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesAurobindo pharmaIntas pharmaceuticalsIntellectual propertyHetero labsSun pharmaceutical

US drops price-fixing case against former Taro Pharmaceutical executive

US drops price-fixing case against former Taro Pharmaceutical executive
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.

United statesR barclay surrickHector armando kellumMike scarcellaSpencer flemingKristina sricaTaro pharmaceutical industriesUs district courtThomson reuters trust principlesJustice departmentIndia sun pharmaceutical industriesAra aprahamianBob gageSun pharmaceuticalEastern districtGage spencer

NPPA makes 33 fixed-dose combination drugs cheaper, brings them under regulation

The 33 drugs includes two each from JB Chemicals and Pharmaceuticals, Eris Lifesciences, Zydus Healthcare, Cipla, Sun Pharmaceutical, and Sanofi India and one from Torrent Pharma.

Delhi high courtServices taxNational pharmaceutical pricing authorityEris lifesciencesZydus healthcareSun pharmaceuticalSanofi indiaMaximum retail priceJb chemicals and pharmaceuticalsEris lifesciencesZydus healthcareSun pharmaceuticalNational pharmaceutical pricing authority nppa

upside potential: Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%

Soon after the announcement by the US Fed two weeks back, the mood on the Street has once again turned in favor of bulls. Whether it is Sensex or Nifty, the underlying bias has once again turned bullish, specially in midcap space. But one headwind remains valuation is still at a higher level. These selected stocks depict a strong upward trajectory in their overall average score which is based on five key pillars i.e. earnings, fundamentals, relative valuation, risk and price momentum. This implies there has been a significant improvement in market outlook in the given time frame.

Market researchUnlimited accessEconomic timesSaver saleMembershipclaim offerPrime storyDebit cardsIncludes docubayEconomic times storiesIndustry trendsVirtual eventsUpside potentialSun pharmaceuticalStocks to buyStock report plusSagar cements

Aurobindo Pharma posts 84% jump in Q2 profit on strong overseas demand

Aurobindo Pharma posts 84% jump in Q2 profit on strong overseas demand
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

Andhra pradeshUnited statesNithyananda reddyIndia aurobindo pharma ltdAurobindo pharma ltdChairman nithyananda reddySun pharmaceutical